Muna Therapeutics
Jakob brings 25 years of experience in small molecule medicinal chemistry, drug discovery and technology in biopharma.
Prior to joining Muna, he was the head of small molecule external innovation at Roche responsible for scouting, and developing novel early stage therapeutic and technology programs with external partners.
This person is not in any offices
Muna Therapeutics
1 followers
Muna Therapeutics discovers and develops therapies that slow or stop neurodegenerative diseases such as alzheimer’s and parkinson's.